TranS1 clocks narrower Q1 loss, shares leap
TranS1 Inc. (Nasdaq:TSON) said after Thursday’s close that it recorded a narrower-than-expected net loss in the first-quarter, shooting shares higher in morning trading. The medical device company attributed the bottom-line to more spine surgeons adopting the AxiaLIF procedure and a broadening of clinical indications for existing surgeon customers as they gain experience with the procedure and the clinical benefits to their patients.
Shares advanced 14%, or $1.94, to $15.79 at 10:18 a.m. ET. For detailed price information and recent news stories about TranS1, click TSON.
